Editor's note: This is the fifth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.
Editor's note: This is the fourth in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.
Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.
Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.
(CIDRAP News) The US Department of the Treasury this week announced the results of a recent exercise to test the resiliency of the nation's financial services sector in an influenza pandemic, revealing that few firms were well prepared and most needed to improve their all-hazards plans.
Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) A federal interagency working group yesterday released a draft report detailing how the government would allocate limited vaccine supplies if a severe influenza pandemic grips the United States, offering a tiered approach that flags key health and public safety personnel and children as top priorities.
(CIDRAP News) The World Health Organization (WHO) today estimated that by 2010 the world may be equipped to make enough pandemic influenza vaccine to immunize 4.5 billion peoplevastly more than in previous projections, though still well short of the world's population of 6.7 billion.
(CIDRAP News) The US government's pandemic influenza preparedness plans need to pay more attention to children, especially their need for antiviral drugs and the effects of prolonged school closings, according to a report released today by public health and pediatrics experts.
